pdf

美迈斯的中国业务组在办理区域内一些最有开创性和最复杂的跨境收购案方面已有多年经验。《法律500强》认为我们拥有“庞大且活跃的团队”及“明确的负责人”。 《钱伯斯与合伙人》也给予同样的积极评价,称我们“在市场上非常活跃且享有声誉”,并且特别指出我们“在中国非常接地气”。

  • 我们的价值定位是我们处理跨境交易中所涉及的各种复杂问题的能力。从处理尽职调查和文档工作的中国当地的大型团队,到周密的结构安排、税务、知识产权和劳动法咨询,再到通过层层手续获得必要的监管和政府批准(无论在北京还是华盛顿),美迈斯中国业务组的团队拥有的丰富资源和经验为涉华跨境交易中的买方和卖方提供了竞争优势。

    • 美迈斯代理了中国的媒体和出版业公司凤凰教育对美国伊利诺伊州的Publication International Ltd.儿童图书业务收购一案。除了收购协议的架构安排和谈判,美迈斯还协助凤凰教育在中国(上海)自由贸易试验区设立了一家控股公司,并通过谈判达成了一项涉及仓储、信息技术服务、销售队伍和会计的综合性过渡协议。此项交易被《中国交易律师》杂志评为中国出版业有史以来最大的跨境交易。

    • 一个涉及美迈斯多个代表处和业务组的团队代理中国本土的基因研究和测序公司华大基因以1.176亿美元收购Complete Genomics一案,并成功地击退了对该交易的一项恶意竞标。这是首起中国公司成功收购美国上市公司案例。在该交易宣布后不久,Illumina, Inc. 发起了对Complete Genomics的恶意竞购。美迈斯采取了反垄断和公司层面的组合防御措施最终击退了Illumina的竞购。我们还为华大完成美国和中国的监管审批程序提供了指导。我们在该交易中所做的工作获得《金融时报》2013年“美国创新律师”报告的肯定。

雄厚实力

  • 资产收购和出售
  • 拍卖
  • 有争议的交易
  • 代理金融顾问
  • 私有化交易
  • 合营
  • 杠杆买断
  • 合并
  • 代理权争夺
  • 资本重组
  • 拆分和剥离
  • 股票购买和出售
  • 收购准备和咨询
  • 要约收购

Apollo Global Management

O’Melveny provided diligence and documentation services to Apollo in connection with its US$875 million acquisition of Regional Care Hospital Partners from Warburg Pincus. Apollo’s investment will finance Regional Care’s plans to develop and further expand its network of hospitals in non-urban areas. Read

Avenue Capital

O’Melveny represented Avenue Capital and its managed funds as an investor in a US$350 million private placement of shares in Euronav NV, an international shipping company focused on sea-borne crude oil transportation.  Read

BB&T Corporation

O’Melveny advised BB&T Corporation in connection with its agreement to acquire National Penn Bancshares, Inc. in a cash and stock transaction for total consideration valued at approximately US$1.8 billion. Read

BGI-Shenzhen

A multi-office, multi-practice O’Melveny team represented BGI Shenzhen, a China based genomic research and sequencing company, in its US$117.6 million acquisition of Complete Genomics and its successful defense of the transaction against a hostile competing bid. Read

Bristol Industries

O’Melveny represented Bristol, one of the few remaining independent manufacturers in the fastener segment of the aerospace industry, in its US$335 million acquisition by Consolidated Aerospace Manufacturing, LLC. O’Melveny counseled Bristol from the initial marketing phase through negotiation and closing of the ultimate sale. Read

Case Study: RSI Home Products

O’Melveny represented RSI Home Products in its definitive agreement and plan of merger with American Woodmark Corporation. Read

Chengwei Capital

O’Melveny represented Chengwei Capital as the main shareholder in Youku Tudou Inc., a leading multi-screen entertainment and media company in China, in Youku Tudou’s definitive agreement to merge an affiliate of Alibaba Group. Read

CoreLogic, Inc.

O’Melveny represented CoreLogic, a global property information, analytics, and data-enabled services provider, in the largest strategic acquisition in its history. Read

Dealertrack Technologies, Inc.

O’Melveny advised Dealertrack Technologies, Inc., a leader in software solutions and services for automotive retailers, in its US$4 billion sale to Cox Automotive, Inc. Read

Exar Corp.

O’Melveny has represented Exar, a New York Stock Exchange-listed supplier of high-performance integrated circuits and system solutions, in more than a dozen acquisitions over the years, including its acquisition of Integrated Memory Logic Limited, a fabless semiconductor company organized as a Cayman Islands exempted company and listed on the Taiwan Stock Exchange. Read

Giant Interactive

O’Melveny successfully defended Giant Interactive, one of China’s leading online game developers and operators, in a shareholder class action seeking to enjoin Giant’s proposed going-private transaction, which O’Melveny also successfully handled.   Read

Giant Interactive

O’Melveny represented Giant Interactive, one of China’s leading online game developers and operators, in its US$3 billion going private transaction. Read

GoGrid

O’Melveny represented GoGrid, a cloud infrastructure service, in its acquisition by Datapipe. Read

Kabam

O’Melveny has advised Kabam, the leader in free-to-play core gaming, in numerous transactions since its establishment in 2006, including all of its venture capital financings and all of its acquisitions. Read

MakerBot

O’Melveny represented MakerBot, a leader in desktop 3D printing, in its acquisition by Stratasys Ltd. Read

Microsemi Corporation

O’Melveny has played a critical role in Microsemi’s growth, having handled some 15 deals for the chipmaker over the past eight years, including its successful US$2.5 billion cash-and-stock “deal jump” to acquire PMC-Sierra and its recent definitive agreement to divest a component of a board level systems and packaging business to Mercury Systems, Inc. for US$300 million. Read

Moelis & Co.

O’Melveny served as counsel to Moelis, financial advisor to Dentsply International in its US$5.5 billion merger with Sirona Dental Systems—a merger that creates the world’s largest maker of dental products. Read

Phoenix Education Publishing Co.

O’Melveny represented Chinese media and publishing company Phoenix Education in its acquisition of children’s book business of Illinois-based Publication International Ltd. (PIL). Read

Samsung Electronics Co. Ltd.

O’Melveny represented Samsung Electronics Co. Ltd. in its acquisition of NeuroLogica Corp., a medical imaging company. Read

Sequoia Capital and China Broadband Capital

O’Melveny represented Sequoia Capital and China Broadband Capital in forming a joint venture with LinkedIn to launch LinkedIn’s China operations, bringing the world’s largest social media platform for professionals to China. Read

Silevo

O’Melveny represented Silevo, a solar photovoltaic cell technology innovator that manufactures high-efficiency, high-performance solar modules, in its acquisition by Elon Musk’s SolarCity Corporation. Read

Skyworks Solutions, Inc.

O’Melveny acted as lead counsel to Skyworks in its US$148.5 million acquisition of a controlling interest in Panasonic Corporation’s filter technology business for smart phones and other mobile applications. Read

Warner Bros.

O’Melveny represented Warner Bros. in its acquisition of Netherlands-based TV producer Eyeworks’ businesses outside the US, comprising holdings throughout 15 territories across Europe, South America, Australia, and New Zealand. Read

WuXi PharmaTech

O’Melveny represented NYSE-listed WuXi PharmaTech (Cayman) Inc., a leading technology company serving the pharmaceutical, biotechnology, and medical device industries in the US and China, in its merger with a group of private equity investors and the company’s founders in a going-private transaction valued at US$3.3 billion. Read
  • Alibaba
  • Apollo Global Management
  • Avenue Capital
  • CA Technologies
  • DealerTrack Technologies
  • GIC
  • Goldman Sachs
  • Honeywell International
  • MHR Fund Management
  • Microsemi Corporation
  • Steel River Infrastructure Partners
  • Warner Bros.